Johns Hopkins University

Minjoo KimMD

MD · Zucker School of Medicine at Hofstra/Northwell

Residency · Osler Internal Medicine Residency, Johns Hopkins University

publications

first author

median RCR

0.18

citations

Publications

2023
Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial.
Frontiers in medicinefirst authorRCR 0.182 citesPMID 36910479

Compiled from public program rosters and open scholarly data (PubMed, OpenAlex, ORCID) with field-normalized impact (NIH iCite RCR). Publication attribution is being actively improved; counts shown are conservative.